Evidence map›Paper›PMID 40682054›Full record

ArticleBMC medical informatics and decision making2025

Machine learning and discriminant analysis model for predicting benign and malignant pulmonary nodules.

Zhi Li, Wenjing Zhang, Jinyi Huang, Ling Lu, Dongming Xie, Jinrong Zhang, Jiamin Liang, Yuepeng Sui, Linyuan Liu, Jianjun Zou and 8 more

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Zhi Li *The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Wenjing Zhang *The Health Management Center, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 511436, China.
Jinyi Huang *The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Ling LuThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Dongming XieThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Jinrong ZhangThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Jiamin LiangThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Yuepeng SuiThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Linyuan LiuThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Jianjun ZouThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Ao LinThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Lei YangThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Fuman QiuThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Zhaoting HuThe Health Management Center, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 511436, China.
Mei WuThe Health Management Center, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 511436, China.
Yibin DengKey Laboratory of Research on Clinical Molecular Diagnosis for High Incidence Diseases in Western Guangxi, Center for Medical Laboratory Science, The Afliated Hospital of Youjiang Medical University for Nationalities, No. 18 Zhongshaner Rd., Youjiang District, Baise, 533000, China. dengyb75@163.com.
Xin ZhangThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China. zhangxin@gzhmu.edu.cn.
Jiachun LuThe Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China. jclu@gzhmu.edu.cn.

Funding

Guangzhou Municipal Health Commission Project 2023C-TS17Guangzhou Science and Technology Bureau Project 2025A03J4485National Natural Science Foundation of China 82373678
6 · The paper itself

Abstract

backgroundPulmonary Nodules (PNs) are a trend considered as the early manifestation of lung cancer. Among them, PNs that remain stable for more than two years or whose pathological results suggest not being lung cancer are considered benign PNs (BPNs), while PNs that conform to the growth pattern of tumors or whose pathological results indicate lung cancer are considered malignant PNs (MPNs). Currently, more than 90% of PNs detected by screening tests are benign, with a false positive rate of up to 96.4%. While a range of predictive models have been developed for the identification of MPNs, there are still some challenges in distinguishing between BPNs and MPNs.

methodsWe included a total of 5197 patients for the case-control study according to the preset exclusion criteria and sample size. Among them, 4735 with BPNs and 2509 with MPNs were randomly divided into training, validation, and test sets according to a 7:1.5:1.5 ratio. Three widely applicable machine learning algorithms (Random Forests, Gradient Boosting Machine, and XGBoost) were used to screen the metrics, and then the corresponding predictive models were constructed using discriminative analysis, and the best performing model was selected as the target model. The model is internally validated with 10-fold cross validation and compared with PKUPH and Block models.

resultsWe collated information from chest CT examinations performed from 2018 to 2021 in the physical examination population and found that the detection rate of PNs was 21.57% and showed an overall upward trend. The GMU_D model constructed by discriminative analysis based on machine learning screening features had an excellent discriminative performance (AUC = 0.866, 95% CI: 0.858-0.874), and higher accuracy than the PKUPH model (AUC = 0.559, 95% CI: 0.552-0.567) and the Block model (AUC = 0.823, 95% CI: 0.814-0.833). Moreover, the cross-validation results also exhibit excellent performance (AUC = 0.866, 95% CI: 0.858-0.874).

conclusionThe detection rate of PNs was 21.57% in the physical examination population undergoing chest CT. Meanwhile, based on real-world studies of PNs, a greater prediction tool was developed and validated that can be used to accurately distinguish between BPNs and MPNs with the excellent predictive performance and differentiation.

Indexed as

Lung NeoplasmsMachine LearningMultiple Pulmonary NodulesSolitary Pulmonary NoduleAdultAgedCase-Control StudiesDiagnosis, DifferentialDiscriminant AnalysisFemaleHumansMaleMiddle AgedDetection rateDiscriminative analysisMachine learningPrediction modelPulmonary nodules

Identifiers

PMID40682054
PMCPMC12275455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.